✦ LIBER ✦

Gemifloxacin as first line treatment for community acquired pneumonia in mexico: A cost—effectiveness study

✍ Scribed by Galindo-Suárez, R.M.; Salinas-Escudero, G.; Muciño-Ortega, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of oral gemifloxacin

✍ Sujata M. Bhavnani; Paul G. Ambrose 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 142 KB

PRS5 COST—EFFECTIVENESS ANALYSIS OF FIRS

✍ G Salinas-Escudero; I Contreras-Hernandez; J Mould-Quevedo; G Davila-Loaiza 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

The Cost-Effectiveness of Bendamustine V

✍ Bertwistle, D.; Munakata, J.; Wehler, E.; Leyva, V.; Valencia, A.; Hernandez, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN26 COST-EFFECTIVENESS AND COST-UTILIT

✍ Salinas-Escudero, G; Contreras-Hernandez, I; Mould-Quevedo, J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

A cost-effectiveness model of escitalopr

✍ Koen Demyttenaere; Michiel E.H. Hemels; Joumana Hudry; Lieven Annemans 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 860 KB

The cost effectiveness of teriparatide a

✍ Daniel R Murphy, Lee J Smolen, Timothy M Klein, Robert W Klein 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 693 KB